Collard Craig A — SEC insider filings

SEC reporting owner CIK 1363558. 49 insider filings on record with FilingPulse; latest filed 2026-11-03.

Transaction summary — filings shown

Covers all 49 filings on record, filed 2021-06-09 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
OPIANT PHARMACEUTICALS, INC. (OPNT)Director86 legs · 48,616 sh · $689,010—11
Sierra Oncology, Inc. (SRRA)Director32 legs · 13,500 sh · $310,863—4
HERON THERAPEUTICS, INC. /DE/ (HRTX)Chief Executive Officer, Director281 leg · 150,000 sh · $137,970—62
TerrAscend Corp. (TSNDF)Director102 legs · 180,000 sh—13

Insider filings — Collard Craig A

FiledFormIssuerReported transactionsSource
2026-11-034HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 50,021 · Tax withholding (F): 12,181 @ $0.28 · Option exercise (M): 34,788 · Tax withholding (F): 8,471 @ $0.28 · Option exercise (M): 50,021 (derivative) @ $0 · Option exercise (M): 34,788 (derivative) @ $0EDGAR
2026-10-214HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 13,797 · Tax withholding (F): 3,360 @ $0.36 · Option exercise (M): 13,797 (derivative) @ $0EDGAR
2026-08-034HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 50,021 · Option exercise (M): 34,789 · Option exercise (M): 50,021 (derivative) @ $0 · Option exercise (M): 34,789 (derivative) @ $0EDGAR
2026-07-204HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0EDGAR
2026-06-254TerrAscend Corp. (TSNDF)Disposition to issuer (D): 150,000 (derivative) · Grant/award (A): 150,000 (derivative)EDGAR
2026-05-044HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 34,789 · Option exercise (M): 50,021 · Option exercise (M): 34,789 (derivative) @ $0 · Option exercise (M): 50,021 (derivative) @ $0EDGAR
2026-04-214HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0EDGAR
2026-04-064HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 62,500 · Option exercise (M): 62,500 (derivative) @ $0EDGAR
2026-02-034HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 34,789 · Option exercise (M): 34,789 (derivative) @ $0EDGAR
2026-02-034HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 800,337 (derivative) @ $0 · Grant/award (A): 800,336 (derivative) @ $0EDGAR
2026-01-204HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0EDGAR
2025-11-044HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 34,789 · Option exercise (M): 34,789 (derivative) @ $0EDGAR
2025-10-214HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0EDGAR
2025-08-044HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 34,789 · Option exercise (M): 34,789 (derivative) @ $0EDGAR
2025-07-224HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0EDGAR
2025-06-254TerrAscend Corp. (TSNDF)Grant/award (A): 433,653 @ $0EDGAR
2025-05-024HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 34,789 · Option exercise (M): 34,789 (derivative) @ $0EDGAR
2025-04-224HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 13,796 · Option exercise (M): 13,796 (derivative) @ $0EDGAR
2025-04-034HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 62,500 · Option exercise (M): 62,500 (derivative) @ $0EDGAR
2025-03-264TerrAscend Corp. (TSNDF)Tax withholding (F): 2,258 @ $0.46EDGAR
2025-02-044HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 1,113,240 (derivative) @ $0 · Grant/award (A): 556,620 (derivative) @ $0EDGAR
2025-01-224HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0EDGAR
2025-01-034TerrAscend Corp. (TSNDF)Tax withholding (F): 71,704 @ $0.65EDGAR
2024-10-214HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0EDGAR
2024-07-224HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0EDGAR
2024-06-204TerrAscend Corp. (TSNDF)Grant/award (A): 163,334 @ $0 · Disposition to issuer (D): 150,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR
2024-04-194HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0EDGAR
2024-04-054HERON THERAPEUTICS, INC. /DE/ (HRTX)Option exercise (M): 62,500 · Option exercise (M): 62,500 (derivative) @ $0EDGAR
2024-01-194HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 1,324,502 (derivative) @ $0 · Grant/award (A): 220,750 (derivative) @ $0EDGAR
2023-11-174HERON THERAPEUTICS, INC. /DE/ (HRTX)Purchase (P): 150,000 @ $0.92EDGAR
2023-08-244HERON THERAPEUTICS, INC. /DE/ (HRTX)Tax withholding (F): 692 @ $1.65EDGAR
2023-06-264TerrAscend Corp. (TRSSF)Grant/award (A): 132,647 @ $0EDGAR
2023-05-244HERON THERAPEUTICS, INC. /DE/ (HRTX)Tax withholding (F): 691 @ $1.45EDGAR
2023-04-054HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 3,000,000 (derivative) @ $0 · Grant/award (A): 250,000 (derivative) @ $0 · Grant/award (A): 4,250,000 (derivative) @ $0EDGAR
2023-03-034OPIANT PHARMACEUTICALS, INC. (OPNT)Disposition to issuer (D): 53,822 @ $20 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0EDGAR
2022-09-274TerrAscend Corp. (TRSSF)Purchase (P): 60,000EDGAR
2022-09-264TerrAscend Corp. (TRSSF)Purchase (P): 120,000EDGAR
2022-07-014Sierra Oncology, Inc. (SRRA)Disposition to issuer (D): 13,500 @ $55 · Disposition to issuer (D): 10,000 (derivative) @ $0 · Disposition to issuer (D): 6,000 (derivative) @ $0EDGAR
2022-06-294TerrAscend Corp. (TRSSF)Grant/award (A): 36,496 · Grant/award (A): 77,918EDGAR
2022-06-144OPIANT PHARMACEUTICALS, INC. (OPNT)Grant/award (A): 2,000 @ $0EDGAR
2022-06-134OPIANT PHARMACEUTICALS, INC. (OPNT)Purchase (P): 1,663 @ $11.50 · Purchase (P): 4,037 @ $10.94EDGAR
2022-05-174OPIANT PHARMACEUTICALS, INC. (OPNT)Purchase (P): 27,150 @ $13.54EDGAR
2022-05-164OPIANT PHARMACEUTICALS, INC. (OPNT)Purchase (P): 3,689 @ $10.49EDGAR
2022-01-104TerrAscend Corp. (TRSSF)Option exercise/expiry (X): 52,939 @ $2.54 · Option exercise/expiry (X): 52,939 (derivative) @ $0EDGAR
2021-11-244Sierra Oncology, Inc. (SRRA)Purchase (P): 5,601 @ $22.95 · Purchase (P): 7,899 @ $23.09EDGAR
2021-09-154OPIANT PHARMACEUTICALS, INC. (OPNT)Purchase (P): 2,500 @ $18.13 · Grant/award (A): 506 @ $17.96 · Grant/award (A): 700 @ $18.07EDGAR
2021-09-134OPIANT PHARMACEUTICALS, INC. (OPNT)Purchase (P): 9,577 @ $18.18EDGAR
2021-06-164OPIANT PHARMACEUTICALS, INC. (OPNT)Grant/award (A): 2,000 @ $0 · Grant/award (A): 2,500 (derivative) @ $0EDGAR
2021-06-094Sierra Oncology, Inc. (SRRA)Grant/award (A): 6,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-05-24 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1363558 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs